10-86919389-C-T

Variant names:

Variant summary

Our verdict is Benign. The variant received -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2

The NM_004329.3(BMPR1A):c.1086C>T(p.Asp362Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000155 in 1,613,010 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.000020 ( 0 hom., cov: 32)

Exomes 𝑓: 0.000015 ( 0 hom. )

Consequence

BMPR1A
NM_004329.3 synonymous

Scores

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 2.10

Publications

0 publications found

Variant links:

Genes affected

BMPR1A (HGNC:1076): (bone morphogenetic protein receptor type 1A) The bone morphogenetic protein (BMP) receptors are a family of transmembrane serine/threonine kinases that include the type I receptors BMPR1A and BMPR1B and the type II receptor BMPR2. These receptors are also closely related to the activin receptors, ACVR1 and ACVR2. The ligands of these receptors are members of the TGF-beta superfamily. TGF-betas and activins transduce their signals through the formation of heteromeric complexes with 2 different types of serine (threonine) kinase receptors: type I receptors of about 50-55 kD and type II receptors of about 70-80 kD. Type II receptors bind ligands in the absence of type I receptors, but they require their respective type I receptors for signaling, whereas type I receptors require their respective type II receptors for ligand binding. [provided by RefSeq, Jul 2008]

BMPR1A Gene-Disease associations (from GenCC):

generalized juvenile polyposis/juvenile polyposis coli
Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Genomics England PanelApp
juvenile polyposis syndrome
Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P
polyposis syndrome, hereditary mixed, 2
Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
hereditary mixed polyposis syndrome
Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
congenital heart defects, multiple types
Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
pulmonary arterial hypertension
Inheritance: Unknown Classification: NO_KNOWN Submitted by: ClinGen

BMPR1A links:

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -15 ACMG points.

BP4

Computational evidence support a benign effect (BayesDel_noAF=-0.35).

BP6

Variant 10-86919389-C-T is Benign according to our data. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86919389-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 232023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

BP7

Synonymous conserved (PhyloP=2.1 with no splicing effect.

BS2

High AC in GnomAdExome4 at 22 AD,Unknown gene.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
BMPR1A	NM_004329.3 link	c.1086C>T	p.Asp362Asp	synonymous_variant	Exon 10 of 13	ENST00000372037.8	NP_004320.2	P36894

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
BMPR1A	ENST00000372037.8 link	c.1086C>T	p.Asp362Asp	synonymous_variant	Exon 10 of 13	1	NM_004329.3	ENSP00000361107.2		P36894

Frequencies

GnomAD3 genomes

AF:

0.0000197

AC:

AN:

152140

Hom.:

Cov.:

show subpopulations

Gnomad AFR

AF:

0.00

Gnomad AMI

AF:

0.00

Gnomad AMR

AF:

0.00

Gnomad ASJ

AF:

0.00

Gnomad EAS

AF:

0.00

Gnomad SAS

AF:

0.00

Gnomad FIN

AF:

0.000283

Gnomad MID

AF:

0.00

Gnomad NFE

AF:

0.00

Gnomad OTH

AF:

0.00

GnomAD2 exomes

AF:

0.0000399

AC:

AN:

250846

AF XY:

0.0000368

show subpopulations

Gnomad AFR exome

AF:

0.00

Gnomad AMR exome

AF:

0.00

Gnomad ASJ exome

AF:

0.00

Gnomad EAS exome

AF:

0.00

Gnomad FIN exome

AF:

0.000277

Gnomad NFE exome

AF:

0.0000353

Gnomad OTH exome

AF:

0.00

GnomAD4 exome

AF:

0.0000151

AC:

AN:

1460752

Hom.:

Cov.:

AF XY:

0.0000165

AC XY:

AN XY:

726690

show subpopulations

African (AFR)

AF:

0.00

AC:

AN:

33444

American (AMR)

AF:

0.00

AC:

AN:

44716

Ashkenazi Jewish (ASJ)

AF:

0.00

AC:

AN:

26132

East Asian (EAS)

AF:

0.00

AC:

AN:

39700

South Asian (SAS)

AF:

0.00

AC:

AN:

86206

European-Finnish (FIN)

AF:

0.000300

AC:

AN:

53420

Middle Eastern (MID)

AF:

0.00

AC:

AN:

5056

European-Non Finnish (NFE)

AF:

0.00000540

AC:

AN:

1111780

Other (OTH)

AF:

0.00

AC:

AN:

60298

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.491

Heterozygous variant carriers

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Exome Het

Variant carriers

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

GnomAD4 genome

AF:

0.0000197

AC:

AN:

152258

Hom.:

Cov.:

AF XY:

0.0000269

AC XY:

AN XY:

74434

show subpopulations

African (AFR)

AF:

0.00

AC:

AN:

41560

American (AMR)

AF:

0.00

AC:

AN:

15296

Ashkenazi Jewish (ASJ)

AF:

0.00

AC:

AN:

3472

East Asian (EAS)

AF:

0.00

AC:

AN:

5176

South Asian (SAS)

AF:

0.00

AC:

AN:

4812

European-Finnish (FIN)

AF:

0.000283

AC:

AN:

10606

Middle Eastern (MID)

AF:

0.00

AC:

AN:

294

European-Non Finnish (NFE)

AF:

0.00

AC:

AN:

68018

Other (OTH)

AF:

0.00

AC:

AN:

2114

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.508

Heterozygous variant carriers

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Alfa

AF:

0.0000987

Hom.:

Bravo

AF:

0.0000151

ClinVar

Significance: Benign/Likely benign

Submissions summary: Benign:6

Revision: criteria provided, multiple submitters, no conflicts

LINK: link

Submissions by phenotype

Hereditary cancer-predisposing syndrome

Benign:3

Jul 25, 2017

Color Diagnostics, LLC DBA Color Health

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Sep 08, 2021

Sema4, Sema4

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:curation

- -

May 22, 2015

Ambry Genetics

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Juvenile polyposis syndrome

Benign:3

Aug 06, 2024

All of Us Research Program, National Institutes of Health

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Oct 21, 2024

Labcorp Genetics (formerly Invitae), Labcorp

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Aug 06, 2024

Myriad Genetics, Inc.

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. -

Computational scores

Source: dbNSFP v4.3

Name

Calibrated prediction

Score

Prediction

BayesDel_noAF

Benign

-0.35

CADD

Benign

8.9

(source)

DANN

Benign

0.48

PhyloP100

2.1

Splicing

Name

Calibrated prediction

Score

Prediction

SpliceAI score (max)

0.0

Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.

Variant summary

Frequency

Consequence

Scores

Clinical Significance

Conservation

Publications

ACMG classification

Transcripts

RefSeq

Ensembl

Frequencies

Age Distribution

ClinVar

Submissions by phenotype

Computational scores

Splicing

Publications

Other links and lift over